Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study.

Bonora, S; Calcagno, A; Cometto, C; Fontana, S; Aguilar, D; D'Avolio, A; Gonzalez de Requena, D; Maiello, A; Dal Conte, I; Lucchini, A; Di Perri, G

Bonora, S; Calcagno, A; Cometto, C; Fontana, S; Aguilar, D; D'Avolio, A; Gonzalez de Requena, D; Maiello, A; Dal Conte, I; Lucchini, A; Di Perri, G.

Affiliation

Bonora S; Department of Infectious Diseases, University of Torino, Ospedale Amedeo di Savoia, C.so Svizzera 164, 10159, Turin, Italy.

Infection ; 40(1): 69-75, 2012 Feb.

Article in En | MEDLINE | ID: mdl-22135137

Subject(s)

HIV Envelope Protein gp41/therapeutic use; HIV Fusion Inhibitors/therapeutic use; HIV Infections/drug therapy; HIV/drug effects; Peptide Fragments/therapeutic use; Reverse Transcriptase Inhibitors/therapeutic use; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Enfuvirtide; Female; HIV/immunology; HIV Envelope Protein gp41/administration & dosage; HIV Fusion Inhibitors/administration & dosage; HIV Infections/virology; Humans; Italy; Male; Middle Aged; Peptide Fragments/administration & dosage; Pilot Projects; Reverse Transcriptase Inhibitors/administration & dosage; Viral Load

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Peptide Fragments / HIV Envelope Protein gp41 / HIV Infections / HIV / Reverse Transcriptase Inhibitors / HIV Fusion Inhibitors Type of study: Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google